Datum: 8.7.2008
The problem with antibiotics is that, eventually, bacteria outsmart them and become resistant. But by targeting the gene that confers such resistance, a new drug may be able to finally outwit them. Rockefeller University scientists tested the new drug, called Ceftobiprole, against some of the deadliest strains of multidrug-resistant Staphylococcus aureus (MRSA) bacteria, which are responsible for the great majority of staphylococcal infections worldwide, both in hospitals and in the community.
Whole article on biovalley
Seminář - Odstranění toxických polutantů z odpadních vod
BioInova, Praha, Česká republika, September 07, 2010
Národní informační den Regiony znalostí a výzkumný potenciál: Aktuální výzvy pro rok 2011
Aula rektorátu VUT, Antonínská 1, Brno, ČR, September 14, 2010
České fórum pro výzkum, vývoj a inovace 2010
Budova E, Mendelova univerzita v Brně, Brno, Česká republika, September 23, 2010
Trends in Nanotechnology International Conference (TNT2010)
Braga, Portugal, September 06-10, 2010
Protein Engineering
Greifswald, Germany, September 06-10, 2010
2010 International Conference on Environmental Engineering and Applications
(ICEEA 2010)
Singapore, September 10-12, 2010
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
© 2006 - 2010 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Cancer cells - Czech Scientists are Working to Find the Achilles‘ Heel of Cancer Cells
Brno University of Technology - university of technology in Brno
Politics versus facts
Cellular armature against HIV